These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29398539)

  • 1. Synthesis, kinetics and inhibition of Escherichia coli Heptosyltransferase I by monosaccharide analogues of Lipid A.
    Nkosana NK; Czyzyk DJ; Siegel ZS; Cote JM; Taylor EA
    Bioorg Med Chem Lett; 2018 Feb; 28(4):594-600. PubMed ID: 29398539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Stories Tryptophans Tell: Exploring Protein Dynamics of Heptosyltransferase I from Escherichia coli.
    Cote JM; Ramirez-Mondragon CA; Siegel ZS; Czyzyk DJ; Gao J; Sham YY; Mukerji I; Taylor EA
    Biochemistry; 2017 Feb; 56(6):886-895. PubMed ID: 28098447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposites Attract:
    Cote JM; Hecht CJS; Patel KR; Ramirez-Mondragon CA; Sham YY; Taylor EA
    Biochemistry; 2020 Sep; 59(34):3135-3147. PubMed ID: 32011131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escherichia coli heptosyltransferase I: investigation of protein dynamics of a GT-B structural enzyme.
    Czyzyk DJ; Sawant SS; Ramirez-Mondragon CA; Hingorani MM; Taylor EA
    Biochemistry; 2013 Aug; 52(31):5158-60. PubMed ID: 23865375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic Characterization and Computational Modeling of
    Hassan BA; Liu ZA; Milicaj J; Kim MS; Tyson M; Sham YY; Taylor EA
    Biochemistry; 2022 Aug; 61(15):1572-1584. PubMed ID: 35861590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of the Escherichia coli Heptosyltransferase III: Exploring substrate specificity in lipopolysaccharide core biosynthesis.
    Mudapaka J; Taylor EA
    FEBS Lett; 2015 Jun; 589(13):1423-9. PubMed ID: 25957775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the Escherichia coli heptosyltransferase WaaC: binary complexes with ADP and ADP-2-deoxy-2-fluoro heptose.
    Grizot S; Salem M; Vongsouthi V; Durand L; Moreau F; Dohi H; Vincent S; Escaich S; Ducruix A
    J Mol Biol; 2006 Oct; 363(2):383-94. PubMed ID: 16963083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide biosynthesis without the lipids: recognition promiscuity of Escherichia coli heptosyltransferase I.
    Czyzyk DJ; Liu C; Taylor EA
    Biochemistry; 2011 Dec; 50(49):10570-2. PubMed ID: 22059588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conserved Conformational Hierarchy across Functionally Divergent Glycosyltransferases of the GT-B Structural Superfamily as Determined from Microsecond Molecular Dynamics.
    Ramirez-Mondragon CA; Nguyen ME; Milicaj J; Hassan BA; Tucci FJ; Muthyala R; Gao J; Taylor EA; Sham YY
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Glycosyltransferases of LPS Core: A Review of Four Heptosyltransferase Enzymes in Context.
    Cote JM; Taylor EA
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of novel small molecule inhibitors of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
    Sharma R; Rani C; Mehra R; Nargotra A; Chib R; Rajput VS; Kumar S; Singh S; Sharma PR; Khan IA
    Appl Microbiol Biotechnol; 2016 Apr; 100(7):3071-85. PubMed ID: 26563552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of liposaccharide heptosyltransferase WaaC with multivalent glycosylated fullerenes: a new mode of glycosyltransferase inhibition.
    Durka M; Buffet K; Iehl J; Holler M; Nierengarten JF; Vincent SP
    Chemistry; 2012 Jan; 18(2):641-51. PubMed ID: 22147564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of first-in-class nanomolar inhibitors of heptosyltransferase I reveals a new aminoglycoside target and potential alternative mechanism of action.
    Milicaj J; Hassan BA; Cote JM; Ramirez-Mondragon CA; Jaunbocus N; Rafalowski A; Patel KR; Castro CD; Muthyala R; Sham YY; Taylor EA
    Sci Rep; 2022 May; 12(1):7302. PubMed ID: 35508636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into Heptosyltransferase I Catalysis and Inhibition through the Structure of Its Ternary Complex.
    Blaukopf M; Worrall L; Kosma P; Strynadka NCJ; Withers SG
    Structure; 2018 Oct; 26(10):1399-1407.e5. PubMed ID: 30122450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-Induced Conformational and Dynamical Changes in a GT-B Glycosyltransferase: Molecular Dynamics Simulations of Heptosyltransferase I Complexes.
    Hassan BA; Milicaj J; Ramirez-Mondragon CA; Sham YY; Taylor EA
    J Chem Inf Model; 2022 Jan; 62(2):324-339. PubMed ID: 34967618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative functional characterization in vitro of heptosyltransferase I (WaaC) and II (WaaF) from Escherichia coli.
    Gronow S; Brabetz W; Brade H
    Eur J Biochem; 2000 Nov; 267(22):6602-11. PubMed ID: 11054112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial neuraminidase inhibitory chalcones from flowers of Coreopsis lanceolata, their kinetic characterization and antibiofilm effect.
    Lee SH; Baiseitova A; Moon SW; Im SY; Park KH
    Phytomedicine; 2024 Jul; 130():155789. PubMed ID: 38824826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation and Suppressor Analysis of the Essential Lipopolysaccharide Transport Protein LptA Reveals Strategies To Overcome Severe Outer Membrane Permeability Defects in Escherichia coli.
    Falchi FA; Maccagni EA; Puccio S; Peano C; De Castro C; Palmigiano A; Garozzo D; Martorana AM; Polissi A; Dehò G; Sperandeo P
    J Bacteriol; 2018 Jan; 200(2):. PubMed ID: 29109183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisynthetic Analogues of Anhydrotetracycline as Inhibitors of Tetracycline Destructase Enzymes.
    Markley JL; Fang L; Gasparrini AJ; Symister CT; Kumar H; Tolia NH; Dantas G; Wencewicz TA
    ACS Infect Dis; 2019 Apr; 5(4):618-633. PubMed ID: 30835428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fragment-based screening to the design of inhibitors of Escherichia coli DsbA.
    Adams LA; Sharma P; Mohanty B; Ilyichova OV; Mulcair MD; Williams ML; Gleeson EC; Totsika M; Doak BC; Caria S; Rimmer K; Horne J; Shouldice SR; Vazirani M; Headey SJ; Plumb BR; Martin JL; Heras B; Simpson JS; Scanlon MJ
    Angew Chem Int Ed Engl; 2015 Feb; 54(7):2179-84. PubMed ID: 25556635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.